Executives from Hexin Health, Merck, Miracle Light, Sequoia, Topgene, and Yuexiu Investment will give their insight into Precision Medicine in China.
Click here to RSVP
The State of Precision Medicine in China
Wed, January 8th, 2:30 to 5:00 pm
No Entrance Fee - Chinese Language
Merck Guangdong Innovation Hub
Unit 10-16, 35/F, Tower A, 51 Luoxuan Rd
Guangzhou International Bio-Island
On Wednesday, January 8th from 2:30 p.m. to 5:30 p.m., GZ Healthcare Drinks, Merck Guangdong Innovation Hub, Yuexiu Industrial Investment Fund, Deloitte, Miracle Light Venture Capital and the UK Department for International Trade will hold an afternoon discussion panel on ‘The State of Precision Medicine in China’ at the Merck Guangdong Innovation Hub on Guangzhou International Biotech Island.
The panel will be moderated by Rita Huang, Senior Trade and Investment Officer, Healthcare and Life Science, and consist of the following executives.
• Chenyang Li - VP and Chief Research Director, Hexin Health
• Mos Mo - Associate Director, Merck Innovation Hub China
• Yujian Shi - R&D Vice President, Topgene
• Lei Xiong - Investment Manager, Yuexiu Industrial Investment Fund
• Wyman Zhao - Partner, Miracle Light Venture Capital
Topics covered will include, the definition of precision medicine, the regulatory environment, hot investment areas, China vs. the West, challenges and opportunities, who will pay, and the growing role of non medical IT/Internet/Big Data companies entering the market.
2:30 p.m. Registration and Networking
3:00 p.m. Welcoming Remarks
3:10 p.m. Introduction of Merck Innovation Hub and Company Pitches
(PHASE Scientific and Richardson Medical Bio-Tech)
3:40 p.m. Deloitte Summary of Next Generation Therapies
4:00 p.m. Panel Discussion
5:00 p.m. Panel Discussion Q&A
5:15 p.m. Networking
Click here to RSVP
Copyright © 2020 Healthcare Drinks, All rights reserved.
Want to change how you receive these emails?
You can update your preferences or unsubscribe.